皮层的异常发育为亨廷顿病的发展奠定了基础
Marine Degennaro1, Sandrine Humbert1, Mariacristina Capizzi1
1Sorbonne Université, Institut du Cerveau - Paris Brain Institute - ICM, Inserm, CNRS, APHP, Hôpital de la Pitié Salpêtrière, Paris, France.
Journal of Huntington's disease
|February 27, 2026
概括
亨廷顿病 (HD) 涉及由于HTT基因突变的早期神经发育变化. 了解这些变化可能会揭示治疗窗口,延迟疾病发病.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 发育生物学 发展生物学
背景情况:
- 亨廷顿病 (HD) 是一种遗传性疾病,由HTT基因的CAG重复扩张引起.
- HTT蛋白对神经元生长和细胞内运输至关重要.
- 在HD中观察到早期的神经发育异常,甚至在临床症状出现之前.
研究的目的:
- 审查HTT的作用及其突变 (mHTT) 在HD神经发育过程中的影响.
- 检查大脑皮层对HD神经病理学的特定贡献.
- 在早期发育过程中识别潜在的治疗干预窗口.
主要方法:
- 综述了将近25年的广泛研究成果.
- 在体外和体内研究的整合.
- 对人类胎儿样本,细胞和动物模型的分析.
主要成果:
- 在HD中神经发育显著改变,在症状前阶段可以检测到异常.
- 突变携带者在诊断前几年可能会表现出微妙的认知,精神或运动缺陷.
- 尽管mHTT一直存在,但长期无症状是HD的典型特征.
结论:
- 在HD的早期发育过程对于理解神经病理学至关重要.
- 在神经发育过程中确定治疗点可能会延长症状前阶段.
- 在发育性可塑性期间的干预可能使大脑能够弥补错误,延迟神经退行.
更多相关视频
09:06Whole-brain Segmentation and Change-point Analysis of Anatomical Brain MRI—Application in Premanifest Huntington's Disease
Published on: June 9, 2018
12.7K
08:27Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
6.7K
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
568
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
568
Alzheimer's Disease: Overview
1.9K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K
